Enhancement of immune tolerance via induction of NK1.1 positive liver- associated-lymphocytes under immunosuppressive conditions

Journal of Hepatology

Volumn 32, Issue 5, 2000, Pages 812-820

  Samsonov, Dimitri ^a   Trop, Shivti ^a   Alper, Ruslana ^a   Diment, Judith ^a   Ilan, Yaron ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

FK506; Immune tolerance; Lymphocytes; NK1.1; Oral tolerance

Indexed keywords

TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034118855     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80251-2     Document Type: Article

References (39)

1. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine and FK 506. Immunology Today. 35:1992;112-132.
2. O'Keffe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neil EA. FK506 and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 357:1992;692-695.
3. Wiederrecht G, Lam E, Hung S. The mechanism of action of FK506 and cyclosporine A. Ann NY Acad Sci. 696:1993;9-19.
4. Jenkins MK, Schwartz RH, Pardoll DM. Effects if cyclosporine A on T cell development and clonal deletion. Science. 241:1988;1655-1657.
5. Moroda T, Kawachi Y, Iiai T, Tsukahara A, Suzuki S, Tada T, et al. Self-reactive forbidden clones are confined to pathways of intermediate T cell receptor cell differentiation under immunosuppressive conditions. Immunology. 91:1997;88-94.
6. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today. 18:1997;335-343.
7. Miller A, Lider O, Roberts AB, Sporn M, Weiner HL. Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc Natl Acad Sci (USA). 89:1992;421-425.
8. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice. J Immunol. 157:1996;2348-2357.
9. Crispe N, Mehal WZ. Strange brew: T cells in the liver. Immun Today. 11:1996;236-245.
10. Ilan Y, Roy Chowdhury N, Sauter B, Thummala NR, Horwitz MS, Davidson A, et al. A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy. Gastroenterology. 114:1998;260A.
11. Callery MP, Kamei T, Flye W. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res. 46:1989;391-394.
12. Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mori T. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats. Surgery. 111:1992;668-676.
13. Yu SY, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsivity and graft tolerance. Surgery. 116:1994;229-234.
14. MacDonald RH. NK1.1+ T cells receptor cells: new clues to their origin, specificity and function. J Exp Med. 182:1995;633-638.
15. Bendelac A. Mouse NK1.1+ T cells. Curr Opin Immunol. 7:1995;367-374.
16. Ilan Y, Weksler-Zangen S, Ben-Horin S, Sestiere M, Diment J, Sauter B, et al. Treatment of experimental colitis through induction of oral tolerance towards colitis extracted proteins. [abstract] Gastroenterology. 114:1998;4100A.
17. Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med. 183:1996;2605-2616.
18. Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y. Liver associated lymphocytes expressing NK1.1 are essential for oral tolerance induction in a murine model. Hepatology. 29:1999;746-755.
19. Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK1.1-mouse: a model to study differentiation of murine NK cells. J Immunol. 137:1988;3742-3747.
20. McDiarmid SV, Busutil RW, Ascher NL. FK 506 compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation. 59:1995;530-536.
21. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK 506 and cyclosporine. Transplantation. 55:1993;1265-1272.
22. Tsukahara A, Seki S, Liai T, Moroda T, Watanabe H, Suzuki S, et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology. 26:1997;301-311.
23. Schultz RJ, Parkes A, Mizoguchu E, Bhan AK, Koyasu S. Development of CD4- CD8- abTCR+NK1.1+ lymphocytes. J Immunol. 157:1996;4379-4389.
24. Doherty DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, et al. Human lymphocytes with dual T cell and natural killer cell phenotype and function in the normal adult liver. [abstract] Hepatology. 26:1997;445A.
25. Collins C, Norris S, McEntee G, Traynor O, Bruno L, Von Boehmer H, et al. RAG1, RAG2 and pre-T cell receptor α chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturation. Eur J Immunol. 26:1996;3114-3118.
26. Garcia-Barcina M, Winnock M, Bidaurrazaga I, Huet S, Biolac Sage P, Balabaud C. Detection of cell adhesions molecules on human liver associated lymphocytes. Immunology. 82:1994;95-98.
27. Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H., Kumagai K, et al. LPS induces NK1. 1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol. 156:1996;2436-2442.
28. Strober W, Kelsall B, Fuss L, Marth T, Ludviksson B, Ehrhardt R, et al. Reciprocal IFN-γ and TGF β responses regulate the occurrence of mucosal inflammation. Immunol Today. 18:1997;61-64.
29. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al. Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science. 261:1993;1321-1324.
30. Ilan Y, Prakash R, Davidson A, Jona VK, Droguett G, Horwitz MS, et al. Oral tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest. 99:1997;1098-1106.
31. Ilan Y, Sauter B, Roy Chowdhury N, Prakash R, Reddy BVN, Sengupta K, et al. Effective adenovirus-mediated gene therapy in the presence of preexisting anti-adenovirus antibodies by oral tolerization of the host. Hepatology. 27:1998;1368-1376.
32. Takahashi M, Ilan Y, Sengupta K, Roy Chowdhury N, Roy Chowdhury J. Induction of tolerance to recombinant adenoviruses by injection into newborn rats: long term amelioration of hyperbilirubinemia in Gunn rats. J Biol Chem. 271:1996;26536-26542.
33. Ilan Y, Jona VK, Sengupta K, Davidson A, Horwitz MS, Roy Chowdhury N, et al. Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenoviruses. Hepatology. 26:1997;949-956.
34. Ilan Y, Droguett G, Roy Chowdhury N, Yongan L, Sengupta K, Thummala NR, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Nat Acad Sci (USA). 94:1997;2587-2593.
35. Ilan Y, Attavar P, Takahashi M, Davidson A, Horwitz M, Guida J, et al. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long term gene therapy in Gunn rats. J Clin Invest. 98:1996;2640-2647.
36. Ilan Y, Prakash R, Jona VK, Sengupta K, Davidson A, Horwitz M, et al. Adoptive transfer of tolerance from rats tolerized to adenoviral antigens allows long term adenovirus-mediated gene therapy in Gunn rats. [abstract] Hepatology. 24:1996;304A.
37. Enomoto A, Nishimura H, Yoshikai Y. Predominant appearance of NK1.1+ T cells producing IL4 may be involved in the increased susceptibility of mice with the Beige mutation during Salmonella infection. J Immunol. 158:1997;2268-2277.
38. Dohert DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, et al. Distinct cytotoxic lymphocytes subsets suggest a role for the liver in immune homeostasis. [abstract] J Hepatol. 28:1998;59A.
39. Jonsson JR, Edwards-Smith CJ, Morotomi Y, Hogan PG, Clouston AD, Lynch SV, et al. Expression of Fas/FasL and bcl2 in normal human liver derived leucocytes. [abstract] Hepatology. 26:1997;269A.